CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS

T

Technische Universität Dresden

Status and phase

Unknown
Phase 3

Conditions

Cannabis Use Disorders

Treatments

Behavioral: Cognitive-behavioral treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT00673647
IIA5-2507DSM407

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of the cognitive-behavioral treatment program CANDIS among n=450 patients with cannabis use disorders in a mulicenter randomized-controlled clinical trial (n=11 outpatient treatment centers).

Enrollment

450 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • motivation to change cannabis use
  • age 16 or older
  • current (12 mth) regular cannabis use (at least 2 days a week)
  • informed consent to the study procedures and assessments

Exclusion criteria

  • current alcohol or any illicit drug dependence syndrome according to DSM-IV other than due to cannabis
  • lifetime history of any psychotic disorder
  • current severe episode of Major depression
  • current panic-agoraphobic disorder (severe)
  • severe learning disability, brain damage or pervasive developmental disorder
  • currently acute suicidality
  • not fluent in german language
  • any other current treatment for cannabis use disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

450 participants in 2 patient groups

1
Experimental group
Description:
Individual psychotherapy including cognitive behavioral components, motivational interviewing techniques and case management
Treatment:
Behavioral: Cognitive-behavioral treatment
2
No Intervention group
Description:
Delayed treatment control group

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems